Completed

Therapeutic Potential of Kappa-Opioids Against Cocaine - 1

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Cocaine-Related Disorders

From 21 to 50 Years
+2 Eligibility Criteria
How is the trial designed

Other

Observational
Study Start: July 1996

Summary

Principal SponsorNational Institute on Drug Abuse (NIDA)
Last updated: January 12, 2017
Sourced from a government-validated database.Claim as a partner
Study start date: July 1, 1996Actual date on which the first participant was enrolled.

The purpose of this study is to characterize the effects of enadoline compared to hydromorphone and butorphanol.

Official TitleTherapeutic Potential of Kappa-Opioids Against Cocaine 
Principal SponsorNational Institute on Drug Abuse (NIDA)
Last updated: January 12, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details
10 patients to be enrolledTotal number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria
Any sexBiological sex of participants that are eligible to enroll.
From 21 to 50 YearsRange of ages for which participants are eligible to join.
Healthy volunteers allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Cocaine-Related Disorders
Criteria
1 inclusion criteria required to participate
piate experienced, healthy

1 exclusion criteria prevent from participating
hysical dependence on opioids, barbiturates or alcohol
Anonymus Profile Image
Ensure optimum compatibilityAdd your profile to know your probability eligibility score.


Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has 1 location
Suspended
Johns Hopkins University (BPRU) Bayview CampusBaltimore, United StatesSee the location

CompletedOne Study Center
Therapeutic Potential of Kappa-Opioids Against Cocaine - 1 | PatLynk